Home » FDA Approves Intravenous Formulation of Pfizer’s Revatio

FDA Approves Intravenous Formulation of Pfizer’s Revatio

November 20, 2009

Pfizer announced that the FDA has approved Revatio (sildenafil) Injection, an intravenous formulation of Revatio.
TradingMarkets

10Mar
FDA Drug GMP Facility Inspections During the Pandemic
16Mar
Pharmaceutical Naming Regulation: Understanding the Latest Developments
18Mar
Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19
23Mar
Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges
30Mar
Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges
06Apr
Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements